Drug Discovery and Development, Third Edition

Drug Discovery and Development, Third Edition provides comprehensive scientific information and insights into maximizing the ability of a multidisciplinary research team to discover and bring new drugs to the marketplace. It explores advances in screening technologies, biotechnology approaches, and preclinical testing, as well as the clinical pharmacology, regulatory, and business aspects of drug development. The book also includes historical perspectives and predicted trends, with contributions from 70+ experts from industry and academia.

\n Format: Paperback / softback
\n Length: 696 pages
\n Publication date: 30 June 2021
\n Publisher: Taylor & Francis Ltd
\n

Drug Discovery and Development, Third Edition serves as a comprehensive resource for maximizing the potential of a multidisciplinary research team in discovering and successfully bringing new drugs to the marketplace. It delves into numerous scientific advancements in the field of drug discovery and development, encompassing areas such as screening technologies, biotechnology approaches, and the evaluation of the efficacy and safety of drug candidates through preclinical testing. This book also significantly broadens its focus to encompass the clinical pharmacology, regulatory, and business aspects of bringing new drugs to market, providing in-depth coverage of essential topics for companies engaged in drug development. Additionally, historical perspectives and predicted trends are offered to provide a comprehensive understanding of the evolving landscape of drug discovery.

The book features a range of valuable features, including:

Emerging Scientific Fields: Highlights emerging scientific fields that are relevant to drug discovery, such as the microbiome, nanotechnology, and cancer immunotherapy. It also introduces novel research tools, such as CRISPR and DNA-encoded libraries, which are revolutionizing the field.

Case Study: Provides a detailed case study detailing the discovery of the anti-cancer drug, lorlatinib. This case study offers insights into the process of drug discovery, from initial research to clinical trials and regulatory approval.

Venture Capitalist Commentary: Offers commentary from venture capitalists on trends and best practices in drug discovery and development. It provides valuable insights into the financial aspects, investment strategies, and challenges faced by companies in the pharmaceutical industry.

Comprehensive Review of Regulations: Provides a comprehensive review of regulations and their impact on drug development. It highlights special populations, orphan drugs, and pharmaceutical compounding, emphasizing the importance of compliance and ethical considerations in research.

Multidiscipline Functioning of an Academic Research Enterprise: Discusses the multidiscipline functioning of an academic research enterprise, including the roles of researchers, scientists, clinicians, and business professionals. It provides valuable insights into the collaboration and teamwork required for successful drug development.

Ethical Concerns in Research: Addresses ethical concerns in research, including issues related to participant consent, privacy, and transparency. It provides guidance on ethical decision-making and promotes responsible conduct in drug discovery.

Contributions by 70+ Experts: Features contributions by over 70+ experts from industry and academia, who are specialists in their respective fields. These experts have developed and practiced the science and business of drug discovery and development, providing valuable insights and perspectives to readers.

Drug Discovery and Development, Third Edition is an essential resource for researchers, scientists, clinicians, pharmaceutical professionals, and students interested in drug discovery and development. It offers up-to-date scientific information, practical insights, and a comprehensive perspective on the complex field, enabling readers to stay informed and contribute to the advancement of medical science.

\n Weight: 1382g\n
Dimension: 176 x 253 x 39 (mm)\n
ISBN-13: 9781032084244\n
Edition number: 3 New edition\n